Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland

A.C. Boyter, D.T. Steinke

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To investigate the trend in prescribing of inhaled corticosteroids and general practitioner (GP) consultations for respiratory diseases. A longitudinal observation study of all prescriptions, from primary care, for inhaled corticosteroids dispensed in Scotland from January 1999 to May 2002 was undertaken. The main outcome measures were the trends in prescribing of inhaled corticosteroids and GP consultations for respiratory diseases. The prescribing of all inhaled corticosteroids has risen over the study period. The rise in prescribing of the combination product containing fluticasone and salmeterol appears not to have been at the expense of the prescribing of fluticasone alone while the prescribing of the budesonide/eformoterol combination may be at the expense of budesonide (BUD) alone. GP consultations for both asthma and chronic obstructive pulmonary disease (COPD) have declined over a similar period. The increased prescribing of inhaled corticosteroids over this period is associated with the increased use of the fluticasone/salmeterol combination rather than an increase in the use of all inhaled corticosteroids. The accompanying fall in number of consultations with GPs may be due to this increased prescribing or a move to nurse led clinics
Original languageEnglish
Pages (from-to)203-209
Number of pages7
JournalPharmacoepidemiology and Drug Safety
Volume14
Issue number3
DOIs
Publication statusPublished - 2005

Fingerprint

Scotland
Adrenal Cortex Hormones
Referral and Consultation
General Practitioners
Budesonide
Nurses' Practice Patterns
Chronic Obstructive Pulmonary Disease
Prescriptions
Longitudinal Studies
Primary Health Care
Asthma
Observation
Outcome Assessment (Health Care)

Keywords

  • prescribing
  • respiratory
  • consultations
  • corticosteroids

Cite this

@article{4219fa2a58594af6a930d777e9a6a1a9,
title = "Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland",
abstract = "To investigate the trend in prescribing of inhaled corticosteroids and general practitioner (GP) consultations for respiratory diseases. A longitudinal observation study of all prescriptions, from primary care, for inhaled corticosteroids dispensed in Scotland from January 1999 to May 2002 was undertaken. The main outcome measures were the trends in prescribing of inhaled corticosteroids and GP consultations for respiratory diseases. The prescribing of all inhaled corticosteroids has risen over the study period. The rise in prescribing of the combination product containing fluticasone and salmeterol appears not to have been at the expense of the prescribing of fluticasone alone while the prescribing of the budesonide/eformoterol combination may be at the expense of budesonide (BUD) alone. GP consultations for both asthma and chronic obstructive pulmonary disease (COPD) have declined over a similar period. The increased prescribing of inhaled corticosteroids over this period is associated with the increased use of the fluticasone/salmeterol combination rather than an increase in the use of all inhaled corticosteroids. The accompanying fall in number of consultations with GPs may be due to this increased prescribing or a move to nurse led clinics",
keywords = "prescribing, respiratory, consultations, corticosteroids",
author = "A.C. Boyter and D.T. Steinke",
year = "2005",
doi = "10.1002/pds.1054",
language = "English",
volume = "14",
pages = "203--209",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
number = "3",

}

Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland. / Boyter, A.C.; Steinke, D.T.

In: Pharmacoepidemiology and Drug Safety, Vol. 14, No. 3, 2005, p. 203-209.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland

AU - Boyter, A.C.

AU - Steinke, D.T.

PY - 2005

Y1 - 2005

N2 - To investigate the trend in prescribing of inhaled corticosteroids and general practitioner (GP) consultations for respiratory diseases. A longitudinal observation study of all prescriptions, from primary care, for inhaled corticosteroids dispensed in Scotland from January 1999 to May 2002 was undertaken. The main outcome measures were the trends in prescribing of inhaled corticosteroids and GP consultations for respiratory diseases. The prescribing of all inhaled corticosteroids has risen over the study period. The rise in prescribing of the combination product containing fluticasone and salmeterol appears not to have been at the expense of the prescribing of fluticasone alone while the prescribing of the budesonide/eformoterol combination may be at the expense of budesonide (BUD) alone. GP consultations for both asthma and chronic obstructive pulmonary disease (COPD) have declined over a similar period. The increased prescribing of inhaled corticosteroids over this period is associated with the increased use of the fluticasone/salmeterol combination rather than an increase in the use of all inhaled corticosteroids. The accompanying fall in number of consultations with GPs may be due to this increased prescribing or a move to nurse led clinics

AB - To investigate the trend in prescribing of inhaled corticosteroids and general practitioner (GP) consultations for respiratory diseases. A longitudinal observation study of all prescriptions, from primary care, for inhaled corticosteroids dispensed in Scotland from January 1999 to May 2002 was undertaken. The main outcome measures were the trends in prescribing of inhaled corticosteroids and GP consultations for respiratory diseases. The prescribing of all inhaled corticosteroids has risen over the study period. The rise in prescribing of the combination product containing fluticasone and salmeterol appears not to have been at the expense of the prescribing of fluticasone alone while the prescribing of the budesonide/eformoterol combination may be at the expense of budesonide (BUD) alone. GP consultations for both asthma and chronic obstructive pulmonary disease (COPD) have declined over a similar period. The increased prescribing of inhaled corticosteroids over this period is associated with the increased use of the fluticasone/salmeterol combination rather than an increase in the use of all inhaled corticosteroids. The accompanying fall in number of consultations with GPs may be due to this increased prescribing or a move to nurse led clinics

KW - prescribing

KW - respiratory

KW - consultations

KW - corticosteroids

U2 - 10.1002/pds.1054

DO - 10.1002/pds.1054

M3 - Article

VL - 14

SP - 203

EP - 209

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 3

ER -